Scientific Sessions 2025  /  Recipes for Success in Heart Failure  /  Discussant: FOOD-HF
Logo

American Heart Association

  31
  0

Final ID:

Discussant: FOOD-HF

  • Lam, Carolyn  ( NATIONAL HEART CENTRE SINGAPORE , Singapore , Singapore )
    • Author Disclosures:
    Carolyn Lam: DO have relevant financial relationships ; Consultant:Alnylam Pharma, AnaCardio, Applied Therapeutics, AstraZeneca:Active (exists now) ; Other (please indicate in the box next to the company name):Us2.ai (Co-founder and Non-Executive Director):Active (exists now) ; Research Funding (PI or named investigator):Roche and Novo Nordisk:Active (exists now) ; Consultant:Quidel Corporation, Radcliffe Group Ltd., Roche and Us2.ai:Active (exists now) ; Consultant:Janssen Research & Development LLC, Medscape/WebMD Global LLC, Merck, Novartis, Novo Nordisk:Active (exists now) ; Consultant:Eli Lilly, Impulse Dynamics, Intellia Therapeutics, Ionis Pharmaceutical:Active (exists now) ; Consultant:Corteria, CPC Clinical Research, Cytokinetics:Active (exists now) ; Consultant:Bayer, Biopeutics, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Recipes for Success in Heart Failure

Monday, 11/10/2025 , 09:45AM - 11:00AM

Late-Breaking Science

More abstracts on this topic:
Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure (pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial)

Nicholls Stephen, Dalessio David

Discussant: POLY-HF

Vardeny Orly

More abstracts from these authors:
AI in Cardiac Imaging: From Research to Real-World Clinical Impact

Saria Suchi, Lam Carolyn, Asselbergs Folkert, Kotecha Dipak

Adiposity and Adipokines and the Comorbidites of HFpEF

Lam Carolyn, Vaduganathan Muthiah

You have to be authorized to contact abstract author. Please, Login
Not Available